Trial Profile
A Phase I, Multiple-Dose, Randomized, Double-Blind, Oral Tyramine Pressor Response Study Comparing CX157 Tablets to Placebo in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs CX 157 (Primary)
- Indications Anxiety disorders; Major depressive disorder
- Focus Adverse reactions
- 12 Jul 2012 New trial record